Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01355848 · ClinicalTrials.gov registry record · Phase 1

Improving Care Provided to Patients Treated in a Level 1 Trauma Center Post-suicide Attempt

A Phase 1 study of Suicidal Ideas, sponsored by University of Washington.

Completed
Registry status
Phase 1
Development phase
40
Enrollment target
1
Study location

NCT01355848 is a Phase 1 study of Suicidal Ideas that has completed, run by University of Washington. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01355848, a Phase 1 study of Suicidal Ideas, has completed, sponsored by University of Washington.

COMPLETED
Registry status
Phase 1
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The aim of the study is to refine, elaborate, and pilot a brief intervention for adult patients following a suicide attempt provided during hospitalization in an acute medical setting. 40 participants will be randomized to receive the brief intervention + care as usual or only care as usual. It is hypothesized that the intervention will be acceptable and feasible to both patients and intervention clinicians.

Conditions Studied

Interventions

  • BEHAVIORAL Brief Intervention for Suicidality

Study Locations (1)

Washington

  • Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2011-05
Est. Completion 2012-04
Phase Phase 1

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT01355848

The ClinicalTrials.gov registry entry for NCT01355848 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Suicidal Ideas appearing as the primary indexed condition, and to 1 intervention - of which Brief Intervention for Suicidality is the first listed.

NCT01355848 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT01355848 about?

NCT01355848 is a clinical study titled "Improving Care Provided to Patients Treated in a Level 1 Trauma Center Post-suicide Attempt". The aim of the study is to refine, elaborate, and pilot a brief intervention for adult patients following a suicide attempt provided during hospitalization in an acute medical setting. 40 participants will be randomized to receive the brief intervention + care as usual or only care as usual. It is h...

What is the current status of trial NCT01355848?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2011-05. Estimated completion is 2012-04.

What conditions does trial NCT01355848 study?

This clinical trial studies the following conditions: Suicidal Ideas.

What interventions are being tested in trial NCT01355848?

The interventions under investigation include: Brief Intervention for Suicidality (BEHAVIORAL).

Who is sponsoring clinical trial NCT01355848?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01355848 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideas

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.